These findings indicate that SGD can promote gastric mucosal synthesis, secretion, and release of PGE2 and increase endogenous EGF levels, thereby promoting gastric mucosal damage repair and enhancing gastric mucosal barrier defense function. The gene discussed is EGF; the disease is specific granule deficiency.